Abstract:Key PointsSince the discovery of induced pluripotent stem cell (iPSC) reprograming, many protocols to generate human neural cells, including specific neuronal subtypes, astrocytes and other glial cells have emerged.Guided differentiation protocols for the production of specific brain cell subtypes from human pluripotent stem cells (hPSCs) follow known developmental pathways. The precise combination of molecular cues allows scientists to guide neural commitment, early regionalization and cell type specification to develop cultures enriched for specific neuronal subtypes.The generation of functional neurons and glia from hPSCs can be markedly improved by controlling the cellular environment in vitro, and advances in developing optimized culture scaffolds, culture media and 3D neural organoid cultures enhance our ability to provide more sophisticated tissue models of the brain. Authentic models of physiological human neuronal tissue in vitro will provide novel means to study human neuronal development and disease.Functional neural cell cultures can also be obtained by converting primary human somatic cells, such as skin fibroblasts, directly into neurons or glia. Direct conversion into induced neurons (iNs) is typically achieved through the overexpression of pro-neuronal transcription factors; alternative methods based on RNA interference or small molecules are also being developed.Direct conversion of human somatic cells into defined neuronal subtypes can be achieved through combined overexpression of general pro-neuronal drivers and secondary lineage-specifying transcription factors.The increasing number of available methods to generate different neural cell types from human skin cells demands a careful consideration of practical as well as conceptual differences between hPSC differentiation and direct conversion methods. Practical concerns may include duration, difficulty, costs, efficiency, available cell numbers and subtypes that can be generated by a certain method; conceptual differences encompass the influence of the respective reprogramming method on the genomic identity of the derived cell culture (for example, clonal or mosaic), their epigenetic state (for example, rejuvenation), as well as whether a certain method recapitulates relevant neurodevelopmental and maturation.

Comparing stem cells, transdifferentiation and brain organoids as tools for psychiatric research

Advances in the knowledge and therapeutics of schizophrenia, major depression disorder, and bipolar disorder from human brain organoid research

Organoids, Assembloids, and Novel Biotechnology: Steps Forward in Developmental and Disease-Related Neuroscience

Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience

Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders

Stem Cell–Based Organoid Models of Neurodevelopmental Disorders

Building on a Solid Foundation: Adding Relevance and Reproducibility to Neurological Modeling Using Human Pluripotent Stem Cells

Modelling human brain development and disease with organoids

Reconstitution of Human Brain Cell Diversity in Organoids via Four Protocols

Differentiation of brain and retinal organoids from confluent cultures of pluripotent stem cells connected by nerve-like axonal projections of optic origin

Brain organoid protocols and limitations

Brain organoids: Human 3D models to investigate neuronal circuits assembly, function and dysfunction

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: from 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Human cerebral organoids — a new tool for clinical neurology research

Aligning Stem Cell Models and Postmortem Studies to Query Striatal Neurodevelopment in Schizophrenia

Electrophysiological Analysis of Brain Organoids: Current Approaches and Advancements

Transcriptomic Mapping of Neural Diversity, Differentiation and Functional Trajectory in iPSC-Derived 3D Brain Organoid Models

A quantitative framework to evaluate modeling of cortical development by neural stem cells.

Applications of Brain Organoids in Neurodevelopment and Neurological Diseases.

Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence

Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges